Healthcare biometrics听allow users to access applications and patient data quickly - clinicians simply touch a fingerprint scanner and get instant access to the records they need on any workstation.
麻豆原创 Analysis and Insights: Global Multi-modal Biometrics in Healthcare 麻豆原创
The global Multi-modal Biometrics in Healthcare market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Multi-modal Biometrics in Healthcare is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Multi-modal Biometrics in Healthcare is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Multi-modal Biometrics in Healthcare is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Multi-modal Biometrics in Healthcare include BioID AG, IriTech, Inc., M2SYS Technology, NEC Corporation, Safran Group, NEC Corporation, Fujitsu Limited, Suprema Inc. and BIO-key International, Inc(US), etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Multi-modal Biometrics in Healthcare market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Multi-modal Biometrics in Healthcare, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Multi-modal Biometrics in Healthcare, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Multi-modal Biometrics in Healthcare revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Multi-modal Biometrics in Healthcare market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Multi-modal Biometrics in Healthcare revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including BioID AG, IriTech, Inc., M2SYS Technology, NEC Corporation, Safran Group, NEC Corporation, Fujitsu Limited, Suprema Inc. and BIO-key International, Inc(US), etc.
By Company
BioID AG
IriTech, Inc.
M2SYS Technology
NEC Corporation
Safran Group
NEC Corporation
Fujitsu Limited
Suprema Inc.
BIO-key International, Inc(US)
HID Global
ASSA ABLOY
ZKteco, Inc.
Segment by Type
Vein Recognition
Voice Recognition
Iris Recognition
Facial Recognition
Fingerprint Recognition
Segment by Application
Hospitals & Clinics
Research & Clinical laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Multi-modal Biometrics in Healthcare in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multi-modal Biometrics in Healthcare companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Multi-modal Biometrics in Healthcare revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Multi-modal Biometrics in Healthcare 麻豆原创 Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Vein Recognition
1.2.3 Voice Recognition
1.2.4 Iris Recognition
1.2.5 Facial Recognition
1.2.6 Fingerprint Recognition
1.3 麻豆原创 by Application
1.3.1 Global Multi-modal Biometrics in Healthcare 麻豆原创 Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals & Clinics
1.3.3 Research & Clinical laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multi-modal Biometrics in Healthcare 麻豆原创 Perspective (2018-2029)
2.2 Global Multi-modal Biometrics in Healthcare Growth Trends by Region
2.2.1 Multi-modal Biometrics in Healthcare 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Multi-modal Biometrics in Healthcare Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Multi-modal Biometrics in Healthcare Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Multi-modal Biometrics in Healthcare 麻豆原创 Dynamics
2.3.1 Multi-modal Biometrics in Healthcare Industry Trends
2.3.2 Multi-modal Biometrics in Healthcare 麻豆原创 Drivers
2.3.3 Multi-modal Biometrics in Healthcare 麻豆原创 Challenges
2.3.4 Multi-modal Biometrics in Healthcare 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Multi-modal Biometrics in Healthcare by Players
3.1.1 Global Multi-modal Biometrics in Healthcare Revenue by Players (2018-2023)
3.1.2 Global Multi-modal Biometrics in Healthcare Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Multi-modal Biometrics in Healthcare 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Multi-modal Biometrics in Healthcare, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Multi-modal Biometrics in Healthcare 麻豆原创 Concentration Ratio
3.4.1 Global Multi-modal Biometrics in Healthcare 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multi-modal Biometrics in Healthcare Revenue in 2022
3.5 Global Key Players of Multi-modal Biometrics in Healthcare Head office and Area Served
3.6 Global Key Players of Multi-modal Biometrics in Healthcare, Product and Application
3.7 Global Key Players of Multi-modal Biometrics in Healthcare, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Multi-modal Biometrics in Healthcare Breakdown Data by Type
4.1 Global Multi-modal Biometrics in Healthcare Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Multi-modal Biometrics in Healthcare Forecasted 麻豆原创 Size by Type (2024-2029)
5 Multi-modal Biometrics in Healthcare Breakdown Data by Application
5.1 Global Multi-modal Biometrics in Healthcare Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Multi-modal Biometrics in Healthcare Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Multi-modal Biometrics in Healthcare 麻豆原创 Size (2018-2029)
6.2 North America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Type
6.2.1 North America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Type (2018-2023)
6.2.2 North America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Type (2024-2029)
6.2.3 North America Multi-modal Biometrics in Healthcare 麻豆原创 Share by Type (2018-2029)
6.3 North America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Application
6.3.1 North America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Application (2018-2023)
6.3.2 North America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Application (2024-2029)
6.3.3 North America Multi-modal Biometrics in Healthcare 麻豆原创 Share by Application (2018-2029)
6.4 North America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Country
6.4.1 North America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Country (2018-2023)
6.4.3 North America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Multi-modal Biometrics in Healthcare 麻豆原创 Size (2018-2029)
7.2 Europe Multi-modal Biometrics in Healthcare 麻豆原创 Size by Type
7.2.1 Europe Multi-modal Biometrics in Healthcare 麻豆原创 Size by Type (2018-2023)
7.2.2 Europe Multi-modal Biometrics in Healthcare 麻豆原创 Size by Type (2024-2029)
7.2.3 Europe Multi-modal Biometrics in Healthcare 麻豆原创 Share by Type (2018-2029)
7.3 Europe Multi-modal Biometrics in Healthcare 麻豆原创 Size by Application
7.3.1 Europe Multi-modal Biometrics in Healthcare 麻豆原创 Size by Application (2018-2023)
7.3.2 Europe Multi-modal Biometrics in Healthcare 麻豆原创 Size by Application (2024-2029)
7.3.3 Europe Multi-modal Biometrics in Healthcare 麻豆原创 Share by Application (2018-2029)
7.4 Europe Multi-modal Biometrics in Healthcare 麻豆原创 Size by Country
7.4.1 Europe Multi-modal Biometrics in Healthcare 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Multi-modal Biometrics in Healthcare 麻豆原创 Size by Country (2018-2023)
7.4.3 Europe Multi-modal Biometrics in Healthcare 麻豆原创 Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Multi-modal Biometrics in Healthcare 麻豆原创 Size (2018-2029)
8.2 China Multi-modal Biometrics in Healthcare 麻豆原创 Size by Type
8.2.1 China Multi-modal Biometrics in Healthcare 麻豆原创 Size by Type (2018-2023)
8.2.2 China Multi-modal Biometrics in Healthcare 麻豆原创 Size by Type (2024-2029)
8.2.3 China Multi-modal Biometrics in Healthcare 麻豆原创 Share by Type (2018-2029)
8.3 China Multi-modal Biometrics in Healthcare 麻豆原创 Size by Application
8.3.1 China Multi-modal Biometrics in Healthcare 麻豆原创 Size by Application (2018-2023)
8.3.2 China Multi-modal Biometrics in Healthcare 麻豆原创 Size by Application (2024-2029)
8.3.3 China Multi-modal Biometrics in Healthcare 麻豆原创 Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Multi-modal Biometrics in Healthcare 麻豆原创 Size (2018-2029)
9.2 Asia Multi-modal Biometrics in Healthcare 麻豆原创 Size by Type
9.2.1 Asia Multi-modal Biometrics in Healthcare 麻豆原创 Size by Type (2018-2023)
9.2.2 Asia Multi-modal Biometrics in Healthcare 麻豆原创 Size by Type (2024-2029)
9.2.3 Asia Multi-modal Biometrics in Healthcare 麻豆原创 Share by Type (2018-2029)
9.3 Asia Multi-modal Biometrics in Healthcare 麻豆原创 Size by Application
9.3.1 Asia Multi-modal Biometrics in Healthcare 麻豆原创 Size by Application (2018-2023)
9.3.2 Asia Multi-modal Biometrics in Healthcare 麻豆原创 Size by Application (2024-2029)
9.3.3 Asia Multi-modal Biometrics in Healthcare 麻豆原创 Share by Application (2018-2029)
9.4 Asia Multi-modal Biometrics in Healthcare 麻豆原创 Size by Region
9.4.1 Asia Multi-modal Biometrics in Healthcare 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Multi-modal Biometrics in Healthcare 麻豆原创 Size by Region (2018-2023)
9.4.3 Asia Multi-modal Biometrics in Healthcare 麻豆原创 Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Multi-modal Biometrics in Healthcare 麻豆原创 Size (2018-2029)
10.2 Middle East, Africa, and Latin America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Multi-modal Biometrics in Healthcare 麻豆原创 Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Multi-modal Biometrics in Healthcare 麻豆原创 Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Multi-modal Biometrics in Healthcare 麻豆原创 Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 BioID AG
11.1.1 BioID AG Company Details
11.1.2 BioID AG Business Overview
11.1.3 BioID AG Multi-modal Biometrics in Healthcare Introduction
11.1.4 BioID AG Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.1.5 BioID AG Recent Developments
11.2 IriTech, Inc.
11.2.1 IriTech, Inc. Company Details
11.2.2 IriTech, Inc. Business Overview
11.2.3 IriTech, Inc. Multi-modal Biometrics in Healthcare Introduction
11.2.4 IriTech, Inc. Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.2.5 IriTech, Inc. Recent Developments
11.3 M2SYS Technology
11.3.1 M2SYS Technology Company Details
11.3.2 M2SYS Technology Business Overview
11.3.3 M2SYS Technology Multi-modal Biometrics in Healthcare Introduction
11.3.4 M2SYS Technology Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.3.5 M2SYS Technology Recent Developments
11.4 NEC Corporation
11.4.1 NEC Corporation Company Details
11.4.2 NEC Corporation Business Overview
11.4.3 NEC Corporation Multi-modal Biometrics in Healthcare Introduction
11.4.4 NEC Corporation Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.4.5 NEC Corporation Recent Developments
11.5 Safran Group
11.5.1 Safran Group Company Details
11.5.2 Safran Group Business Overview
11.5.3 Safran Group Multi-modal Biometrics in Healthcare Introduction
11.5.4 Safran Group Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.5.5 Safran Group Recent Developments
11.6 NEC Corporation
11.6.1 NEC Corporation Company Details
11.6.2 NEC Corporation Business Overview
11.6.3 NEC Corporation Multi-modal Biometrics in Healthcare Introduction
11.6.4 NEC Corporation Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.6.5 NEC Corporation Recent Developments
11.7 Fujitsu Limited
11.7.1 Fujitsu Limited Company Details
11.7.2 Fujitsu Limited Business Overview
11.7.3 Fujitsu Limited Multi-modal Biometrics in Healthcare Introduction
11.7.4 Fujitsu Limited Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.7.5 Fujitsu Limited Recent Developments
11.8 Suprema Inc.
11.8.1 Suprema Inc. Company Details
11.8.2 Suprema Inc. Business Overview
11.8.3 Suprema Inc. Multi-modal Biometrics in Healthcare Introduction
11.8.4 Suprema Inc. Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.8.5 Suprema Inc. Recent Developments
11.9 BIO-key International, Inc(US)
11.9.1 BIO-key International, Inc(US) Company Details
11.9.2 BIO-key International, Inc(US) Business Overview
11.9.3 BIO-key International, Inc(US) Multi-modal Biometrics in Healthcare Introduction
11.9.4 BIO-key International, Inc(US) Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.9.5 BIO-key International, Inc(US) Recent Developments
11.10 HID Global
11.10.1 HID Global Company Details
11.10.2 HID Global Business Overview
11.10.3 HID Global Multi-modal Biometrics in Healthcare Introduction
11.10.4 HID Global Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.10.5 HID Global Recent Developments
11.11 ASSA ABLOY
11.11.1 ASSA ABLOY Company Details
11.11.2 ASSA ABLOY Business Overview
11.11.3 ASSA ABLOY Multi-modal Biometrics in Healthcare Introduction
11.11.4 ASSA ABLOY Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.11.5 ASSA ABLOY Recent Developments
11.12 ZKteco, Inc.
11.12.1 ZKteco, Inc. Company Details
11.12.2 ZKteco, Inc. Business Overview
11.12.3 ZKteco, Inc. Multi-modal Biometrics in Healthcare Introduction
11.12.4 ZKteco, Inc. Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.12.5 ZKteco, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
BioID AG
IriTech, Inc.
M2SYS Technology
NEC Corporation
Safran Group
NEC Corporation
Fujitsu Limited
Suprema Inc.
BIO-key International, Inc(US)
HID Global
ASSA ABLOY
ZKteco, Inc.
听
听
*If Applicable.
